Device Surgical Care

Actifuse

Payments companies reported to CMS as associated with Actifuse. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$78Kassociated payments (2023-2025)
120clinicians with associated payments
1company reporting

By year

2023 $15K
2024 $55K
2025 $8,287

Payments reported as associated with Actifuse, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $42K
Neurological Surgery $13K
Orthopaedic Surgery of The Spine $11K
Orthopaedic Surgery $2,229
Physician Assistant $1,873
Neurology (Psychiatry & Neurology) $978

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Actifuse

These are the largest totals companies reported as associated with Actifuse. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ahmet Kilic Columbus, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $8,075.00
Yuji Kawano Boston, MA Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,843.45
Ashish Sahai Boca Raton, FL Orthopaedic Surgery of The Spine $7,695.00
David Caparrelli Manchester, NH Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,530.00
Michael Robich Greeley, CO Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,530.00
David Zapata Lawrenceville, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $5,910.00
Bradley Taylor Boca Raton, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $5,360.00
John Gillick Newark, NJ Neurological Surgery $3,040.60
Pankaj Agarwalla Newark, NJ Neurological Surgery $2,015.42
Colin Harris Wayne, NJ Orthopaedic Surgery of The Spine $1,155.28

Prescribed Actifuse?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.